References
- Mitka M. Task force: nontraditional markers add little to heart risk assessment. JAMA 2009;302:2192–3.
- Abelson R. New York Times. March 13, 2008. www.nytimes.com/2008/03/13/business/13scan.html?pagewanted=print (Accessed April 19, 2010).
- Peter J, Neumann PJ, Tunis SR. Medicare and medical technology—the growing demand for relevant outcomes. N Engl J Med 2010;362:377–9.
- Mitka M. Research offers only a limited view of imaging's effect on patient outcomes. JAMA 2010;303:599–600.
- Bissell MG. Laboratory-related measures of patient outcomes: an introduction. Washington: AACC Press, 2000194.
- Bruns DE. Laboratory-related outcomes in health care. Clin Chem 2001;47:1547–52.
- Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, . Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276: 637–9.
- Durbridge TC, Edwards F, Edwards RG, Atkinson M. Evaluation of benefits of screening tests done immediately on admission to hospital. Clin Chem 1976;22:968–71.
- Schein OD, Katz J, Bass EB, Tielsch JM, Lubomski LH, Feldman MA, . The value of routine preoperative medical testing before cataract surgery. N Engl J Med 2000;342:168–75.
- Bossuyt PM, Lijmer JG, Mol BW. Randomised comparisons of medical tests: sometimes invalid, not always efficient. Lancet 2000;356:1844–7.
- Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem 2001;47:209–14.
- Boyd JC, Bruns DE. Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests: Meeting clinical needs. Methods Enzymol 2009;467: 411–33
- Karon BS, Boyd JC, Klee GG. Glucose meter performance criteria for tight glycemic control estimated by simulation modeling. Clin Chem 2010;56:(in press).